AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Explore this paper's citation graph
Summary
The development of the present statement involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that aggressive comprehensive risk factor management improves survival, reduces recurrent events and the need for interventional procedures, and improves quality of life for patients with established coronary disease.
- Type
- article
- Published
- 2006-05-16
- Cited by
- 2,210
- References
- 76
- Access
- Open access
- OpenAlex
- https://openalex.org/W2167067204
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38293285
Keywords
Medicine, ATHEROSCLEROTIC VASCULAR DISEASE, Secondary prevention, Atherosclerotic cardiovascular disease, Internal medicine
References
- Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
- Physical Activity And Health: A Report Of The Surgeon General
- Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
- Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
- Get with the guidelines for cardiovascular secondary prevention: pilot results.
- The american stroke association : A division of the american heart association
- Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)
- Efficacy and safety of cholesterol-lowering treatment.
- The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
- Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
- Physical activity and public health.
- Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative.
- Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
- Prevention and control of influenza.
- Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
- Standards of Medical Care in Diabetes: Response to Power
- AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
- Standards of medical care in diabetes.
Cited by
- Adherence to Evidence-Based Therapies After Acute Coronary Syndrome: A Retrospective Population-Based Cohort Study Linking Hospital, Outpatient, and Pharmacy Health Information Systems in Valencia, Spain
- GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design
- Impact of Carotid Endarterectomy on Medical Secondary Prevention After a Stroke or a Transient Ischemic Attack: Results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry
- Management of coronary artery disease in patients with type 2 diabetes mellitus
- Exercise training in the management of cardiac failure and ischaemic heart disease.
- Preventing Cardiovascular Disease in Women: An Update
- LESSONS FROM ONTARGET
- Improving weight loss in cardiac rehabilitation.
- Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program
- A predictor of atheroma progression in patients achieving very low levels of low-density lipoprotein cholesterol.
- Statin prescription is essential in peripheral vascular disease.
- Promoting self-determined motivation for exercise in cardiac rehabilitation: the role of autonomy support.
- Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease.
- Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?
- Approach to Smoking Cessation in the Patient With Vascular Disease
- A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk
- ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
- The role of myocardial scintigraphy in the assessment of cardiovascular risk in patients with end-stage chronic kidney disease on the waiting list for renal transplantation.
- Psychosocial Concerns and Interventions for Patients and Their Identified Support Givers to Help Cope With Acute Manifestations of Advanced Coronary Artery Diseases
- Early Antiplatelet Therapy in Coronary Artery Bypass Grafting a Calculated Benefit
Related papers
- P5083Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy
- Revised Guidelines: Secondary Prevention and Risk Reduction in Patients with Atherosclerotic Disease
- Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease.
- Atherosclerosis: a major cause of peripheral vascular disease.
- The Continuing Scourge of Atherosclerotic Cardiovascular Disease: Importance of Multidisciplinary and Innovative Person-Centred Approaches.